The potential neuroprotective effects of cannabinoids against paclitaxel-induced peripheral neuropathy: study on neurite outgrowth.

Chemotherapy-induced peripheral neuropathy (CIPN) is a shared burden for 68.1% of oncological patients undergoing chemotherapy with Paclitaxel (PTX). The symptoms are intense and troublesome, patients reporting paresthesia, loss of sensation, and dysesthetic pain.